Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Ner Formule 8 mg Tablet is a Health Canada–registered human drug (DIN 00463027) held by Frega Inc., containing Ruta Graveolens. Health Canada lists its status as Cancelled Post Market (status date 13 Feb 2008). Nexara Health has matched 21 registrations of Ruta Graveolens across 4 other regulated markets.

Health Canada registration

DIN00463027
Brand nameNer Formule
Active ingredientRuta Graveolens
Strength8 mg
Dosage formTablet
RouteOral
CompanyFrega Inc.
StatusCancelled Post Market — 13 Feb 2008
ClassHuman
ATC
AHFS92:01.00* ; See footnote
Regulator recordHealth Canada DPD entry · Product monograph

Ruta Graveolens registered in other markets

21 registrations of the same molecule in 4 national registries outside Canada (first 13 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
IrelandRuta gravA. Nelson & Company LimitedPillulesNot marketedHPRA
NetherlandsRuta graveolensBOIRON (Messimy)4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LMUitsluitend apotheek of drogistEU national register
NetherlandsRuta graveolensBOIRON (Messimy)4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LMGlobuliUitsluitend apotheek of drogistEU national register
United Arab EmiratesRuta - Dr. ReckewegPHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO. GMBH, Germany, BENSHEIMMT - 200CDropsActiveEDE
United Arab EmiratesRuta Graveolens - BoironBOIRON, France, Messimy2 DH - 200 CHPillulesActiveEDE
United StatesBestmade Natural Products Ruta GrBestmade Natural ProductsTablet, SolublelistedFDA NDC
United StatesBM Ruta GraveolensBM Private LimitedGlobulelistedFDA NDC
United StatesRuta GraveolensHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesRuta GraveolensHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesRuta GraveolensHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesRuta GraveolensHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesRuta GraveolensHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesRuta GraveolensHahnemann Laboratories, INC.PelletlistedFDA NDC

See every manufacturer of Ruta Graveolens worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Ner Formule (DIN 00463027) marketed in Canada?

No. Health Canada lists DIN 00463027 as Cancelled Post Market as of 13 Feb 2008.

Who holds the Canadian licence for this product?

Frega Inc. is the company of record in the Health Canada Drug Product Database.

Is Ruta Graveolens registered outside Canada?

Yes — Nexara Health has matched 21 registrations in 4 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 00463027, status date 2008-02-13; national medicine registries: EDE, EU national register, FDA NDC, HPRA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 00463027, status date 2008-02-13; national medicine registries: EDE, EU national register, FDA NDC, HPRA.

Health Canada Drug Product Database (DPD), DIN 00463027, status date 2008-02-13; national medicine registries: EDE, EU national register, FDA NDC, HPRA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.